Your browser doesn't support javascript.
loading
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.
Pinho, Raquel; Paiva, Isabel; Jercic, Kristina Gotovac; Fonseca-Ornelas, Luis; Gerhardt, Ellen; Fahlbusch, Christiane; Garcia-Esparcia, Paula; Kerimoglu, Cemil; Pavlou, Maria A S; Villar-Piqué, Anna; Szego, Éva; Lopes da Fonseca, Tomás; Odoardi, Francesca; Soeroes, Szabolcs; Rego, Ana Cristina; Fischle, Wolfgang; Schwamborn, Jens C; Meyer, Thomas; Kügler, Sebastian; Ferrer, Isidre; Attems, Johannes; Fischer, André; Becker, Stefan; Zweckstetter, Markus; Borovecki, Fran; Outeiro, Tiago F.
Afiliação
  • Pinho R; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Paiva I; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Jercic KG; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Fonseca-Ornelas L; Department for Functional Genomics, Center for Translational and Clinical Research, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Gerhardt E; Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
  • Fahlbusch C; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Garcia-Esparcia P; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Kerimoglu C; Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat; Biomedical Research Center of Neurodegenerative Diseases, Barcelona, Spain.
  • Pavlou MAS; Department for Psychiatry and Psychotherapy, University Medical Center, Göttingen, Germany.
  • Villar-Piqué A; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Szego É; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Lopes da Fonseca T; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Odoardi F; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Soeroes S; Institute of Neuroimmunology and Institute for Multiple Sclerosis Research, University Medical Centre Göttingen, Göttingen, Germany.
  • Rego AC; Max Planck Institute for Biophysical Chemistry, Laboratory of Chromatin Biochemistry, Göttingen, Germany.
  • Fischle W; Oxford Nanopore Technologies LTD, Oxford, United Kingdom.
  • Schwamborn JC; Center for Neuroscience and Cell Biology and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Meyer T; Max Planck Institute for Biophysical Chemistry, Laboratory of Chromatin Biochemistry, Göttingen, Germany.
  • Kügler S; King Abdullah University of Science and Technology, Environmental Epigenetics Program, Thuwal, Saudi Arabia.
  • Ferrer I; Development and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Attems J; Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Göttingen, Göttingen, Germany.
  • Fischer A; Department of Neurology, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
  • Becker S; Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat; Biomedical Research Center of Neurodegenerative Diseases, Barcelona, Spain.
  • Zweckstetter M; Institute of Neuroscience, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.
  • Borovecki F; Department for Psychiatry and Psychotherapy, University Medical Center, Göttingen, Germany.
  • Outeiro TF; Department of Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Göttingen Germany.
Hum Mol Genet ; 28(1): 31-50, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30219847
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa-Sinucleína Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alfa-Sinucleína Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article